Recent legal actions have raised concerns about the presence of benzene, a known carcinogen, in popular acne treatments. Lawsuits have been filed against major retailers and manufacturers, including L’Oréal, Walgreens, and Walmart, alleging that their benzoyl peroxide-based acne products contain unsafe levels of this chemical.
These lawsuits stem from independent testing that reportedly detected benzene in various benzoyl peroxide formulations. Benzene is classified by the American Cancer Society as a human carcinogen, and exposure to it is linked to an increased risk of certain cancers.
Specific legal complaints have been lodged with federal courts, including the U.S. District Court for the Southern District of New York and the U.S. District Court for the Northern District of Illinois. These actions are part of a larger trend of litigation concerning chemicals found in consumer products, with the Judicial Panel on Multidistrict Litigation overseeing related cases.
While some brands, like CeraVe, acknowledge the concern and provide information on the differences between benzoyl peroxide and salicylic acid for acne treatment on their official websites, the lawsuits suggest that certain CeraVe products may also be affected.
The legal challenges are being closely monitored, with initial court documents available through platforms like CourtListener and Pacermonitor. The outcome of these cases could impact the availability and formulation of widely used acne medications.
Reference